Literature DB >> 2124968

Mutations introduced along the HTLV-I envelope gene result in a non-functional protein: a basis for envelope conservation?

C Pique1, T Tursz, M C Dokhelar.   

Abstract

The envelope protein of the human T-cell leukemia virus type I (HTLV-I) is highly conserved among the isolates sequenced so far, as opposed to what is observed for the human immunodeficiency virus (HIV) envelope. By linker insertion scanning, we have produced 33 random mutations along the HTLV-I envelope gene, cloned into a eukaryotic expression vector. The resulting envelope products were analysed by immunoprecipitation and syncytia formation after transfection into COS-1 cells. We show here that 25 out of 33 mutations result in a non-functional envelope product as assessed by the lack of ability to form syncytia. In the majority of these mutants, the processing of the envelope gp61 precursor into the mature gp45 and gp20 proteins was affected. We propose that conformational constraints for processing and fusion abilities tend to limit the variability of the HTLV-I envelope. In three mutants, processing was observed but no syncytia were formed. These mutations might affect regions important for HTLV-I envelope functions, such as the receptor binding region.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2124968      PMCID: PMC552206          DOI: 10.1002/j.1460-2075.1990.tb07872.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  47 in total

1.  Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.

Authors:  B R Starcich; B H Hahn; G M Shaw; P D McNeely; S Modrow; H Wolf; E S Parks; W P Parks; S F Josephs; R C Gallo
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

2.  Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion.

Authors:  T J Matthews; K J Weinhold; H K Lyerly; A J Langlois; H Wigzell; D P Bolognesi
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

3.  Identification of conserved and divergent domains within the envelope gene of the acquired immunodeficiency syndrome retrovirus.

Authors:  R L Willey; R A Rutledge; S Dias; T Folks; T Theodore; C E Buckler; M A Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

4.  Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients.

Authors:  M Alizon; S Wain-Hobson; L Montagnier; P Sonigo
Journal:  Cell       Date:  1986-07-04       Impact factor: 41.582

Review 5.  The structure and function of the hemagglutinin membrane glycoprotein of influenza virus.

Authors:  D C Wiley; J J Skehel
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

6.  HTLV-I associated myelopathy, a new clinical entity.

Authors:  M Osame; K Usuku; S Izumo; N Ijichi; H Amitani; A Igata; M Matsumoto; M Tara
Journal:  Lancet       Date:  1986-05-03       Impact factor: 79.321

7.  Molecular characterization of human immunodeficiency virus from Zaire: nucleotide sequence analysis identifies conserved and variable domains in the envelope gene.

Authors:  A Srinivasan; R Anand; D York; P Ranganathan; P Feorino; G Schochetman; J Curran; V S Kalyanaraman; P A Luciw; R Sanchez-Pescador
Journal:  Gene       Date:  1987       Impact factor: 3.688

8.  Rates of evolution of the retroviral oncogene of Moloney murine sarcoma virus and of its cellular homologues.

Authors:  T Gojobori; S Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

9.  Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.

Authors:  A Gessain; F Barin; J C Vernant; O Gout; L Maurs; A Calender; G de Thé
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

10.  Identification of gag and env gene products of human T-cell leukemia virus (HTLV).

Authors:  S Hattori; T Kiyokawa; K Imagawa; F Shimizu; E Hashimura; M Seiki; M Yoshida
Journal:  Virology       Date:  1984-07-30       Impact factor: 3.616

View more
  34 in total

1.  Neutralizing human monoclonal antibodies to conformational epitopes of human T-cell lymphotropic virus type 1 and 2 gp46.

Authors:  K G Hadlock; J Rowe; S Perkins; P Bradshaw; G Y Song; C Cheng; J Yang; R Gascon; J Halmos; S M Rehman; M S McGrath; S K Foung
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  The ectodomain of the human T-cell leukemia virus type 1 TM glycoprotein is involved in postfusion events.

Authors:  A R Rosenberg; L Delamarre; C Pique; D Pham; M C Dokhélar
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry.

Authors:  David Ghez; Yves Lepelletier; Sophie Lambert; Jean-Marie Fourneau; Vincent Blot; Sébastien Janvier; Bertrand Arnulf; Peter M van Endert; Nikolaus Heveker; Claudine Pique; Olivier Hermine
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

4.  The SU and TM envelope protein subunits of bovine leukemia virus are linked by disulfide bonds, both in cells and in virions.

Authors:  E R Johnston; K Radke
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

5.  Molecular characterization of the env gene from Brazilian field isolates of Bovine leukemia virus.

Authors:  Marcelo Fernandes Camargos; Ariel Pereda; Daniel Stancek; Maurílio Andrade Rocha; Jenner Karlisson Pimenta dos Reis; Irene Greiser-Wilke; Rômulo Cerqueira Leite
Journal:  Virus Genes       Date:  2006-08-18       Impact factor: 2.332

6.  Identification of functional regions in the human T-cell leukemia virus type I SU glycoprotein.

Authors:  L Delamarre; C Pique; D Pham; T Tursz; M C Dokhélar
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

7.  Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations.

Authors:  A Gessain; R C Gallo; G Franchini
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

8.  Multiple functions for the basic amino acids of the human T-cell leukemia virus type 1 matrix protein in viral transmission.

Authors:  I Le Blanc; A R Rosenberg; M C Dokhélar
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

9.  Development of a novel surrogate virus for human T-cell leukemia virus type 1: inhibition of infection by osteoprotegerin.

Authors:  Kazu Okuma; Kevin P Dalton; Linda Buonocore; Elizabeth Ramsburg; John K Rose
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

10.  Isolation of a human T-lymphotropic virus type I strain from Australian aboriginals.

Authors:  I Bastian; J Gardner; D Webb; I Gardner
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.